Joseph Caprini/LinkedIn
Nov 15, 2025, 08:19
Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
Joseph Caprini, Senior Clinician Educator at The University of Chicago Pritzker School of Medicine, shared on LinkedIn:
”Just released my UIP 2025 session with Alfonso J. Tafur MD MS MBA RPVI on measuring VTE recurrence risk and tailoring treatment.
Dr. Caprini discusses how to pinpoint patients at greatest risk of VTE recurrence and highlights the value of the Caprini Risk Score in guiding long-term prevention.
He also explains how biomarkers, imaging, clinical history, and practical decision frameworks support more precise assessments and determine when extended prophylaxis is warranted.
Stay updated with Hemostasis Today.
-
Dec 16, 2025, 16:34Mads Krogsgaard Thomsen on Novo Nordisk Haemophilia Foundation’s Support for Haemoglobinopathies
-
Dec 16, 2025, 16:22Leonardo Furtado Freitas Presents a Rare Hemorrhagic Hemangioblastoma Case
-
Dec 16, 2025, 16:14Nicolas Gendron on Sustainability in Anticoagulation and DOACs
-
Dec 16, 2025, 15:39Reza Shojaei: Every Expired Unit of Blood Tells a Story
-
Dec 16, 2025, 14:03Francesco Lo Monaco on Rethinking Blood Pressure: The Major Problem with How We Understand It
-
Dec 16, 2025, 14:03Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
-
Dec 16, 2025, 14:02Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms
-
Dec 16, 2025, 13:58AHA Awards Shubham Misra Postdoc Grant for LVO Stroke Biomarker Research
-
Dec 16, 2025, 13:00ScholarGPS Ranks Emmanuel J. Favaloro No. 1 in the World for Hemostasis